Skip to main content
/
Lytix Biopharma AS (OSL:LYTIX)
Norway flag Norway · Delayed Price · Currency is NOK
4.800
-0.090 (-1.84%)
Apr 2, 2025, 4:25 PM CET

Lytix Biopharma AS Revenue

In the year 2024, Lytix Biopharma AS had annual revenue of 11.13M NOK with 178.98% growth. Lytix Biopharma AS had revenue of 377.00K in the quarter ending December 31, 2024.

Revenue
11.13M
Revenue Growth
+178.98%
P/S Ratio
23.78
Revenue / Employee
1.39M
Employees
8
Market Cap
333.80M

Revenue Chart

Created with Highcharts 11.4.8Lytix Biopharma AS Revenue - Annual4.07M​4.07M19.31M​19.31M11.03M​11.03M3.99M​3.99M11.13M​11.13M20202021202220232024-5M10M15M20M

History

Fiscal Year End Revenue Change Growth
Dec 31, 202411.13M7.14M178.98%
Dec 31, 20233.99M-7.04M-63.82%
Dec 31, 202211.03M-8.28M-42.87%
Dec 31, 202119.31M15.23M373.91%
Dec 31, 20204.07M-2.27M-35.73%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 562.60M
Nordhealth AS 537.23M
Photocure ASA 525.39M
Vistin Pharma ASA 429.50M
Hofseth BioCare ASA 265.54M
Omda AS 426.27M
ArcticZymes Technologies ASA 108.11M
Nykode Therapeutics AS 104.04M
Revenue Rankings